SCR-LIP-000670 · Claim · machine-readable JSON →

No clinical study has evaluated gestrinone in lipedema, so its use as a lipedema treatment lacks direct clinical evidence.

General proposition consolidated from 2 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
therapeutic
Knowledge state
Evidence gap
Evidence certainty
high (GRADE)
Evidence
3 source(s) · by Amato
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20252026Lack of Scientific Evidence for the Use of Gestrinone in the Treatment of Lipedema: A Systematic Review — Amato et al. (2025) · consistentGestrinone, lipedema, and the limits of theoretical extrapolation in clinical practice: a critical narrative review (2026) · consistentTreatment Strategies for Lipedema: A Scoping Review on liposuction, compression therapy, bariatric surgery and pharmacological treatment (2026) · consistent

Evidence (3)

Context (PECO)

Populationpatients with lipedema
Conditionlipedema
Exposuregestrinone (off-label, incl. subcutaneous implants)
Comparatorevidence-based conservative care
Outcomeno eligible evidence of efficacy/safety
Scopesystematic review to July 2025

Answers these questions

Gaps & caveats

Change log